Dr. Sturdivant successfully defended his PhD thesis, “The Distinct Roles of APOBEC3A and APOBEC3B in APOBEC3-Driven Mutagenesis in Urothelial Carcinoma,” under the mentorship of the Dr. William Kim.
Dr. Sturdivant’s new position will be as a Postdoctoral Research Associate.
Publications
Tumor-derived Extracellular Vesicles Induce ER Stress to Drive Tolerogenic Dendritic Cell Development in the Tumor Microenvironment. Wang X, Plebanek MP, Nguyen YV, Bazaz MR, Sturdivant M, Theivanthiran B, Hanks BA. bioRxiv [Preprint]. 2026 Feb 12:2026.02.10.705213. doi: 10.64898/2026.02.10.705213. PMID: 41727176. PMC12918792
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling. Sturdivant MS, Truong AS, Zhou M, Toomer ED, Beckabir W, Raupp J, Manocha U, Zambrano IA, Tan HJ, Bjurlin MA, Smith AB, Rose TL, Milowsky MI, Wobker SE, Gessner KH, Damrauer JS, Kim WY. Nat Commun. 2025 Dec 14;17(1):334. doi: 10.1038/s41467-025-67033-8. PMID: 41390483
GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling. DeVito NC, Nguyen YV, Sturdivant M, Plebanek MP, Villarreal KA, Yarla N, Jain V, Aksu M, Beasley GM, Theivanthiran B, Hanks BA. Cancer Res. 2025 May 2;85(9):1644-1662. doi: 10.1158/0008-5472.CAN-24-1130. PMID: 39970333
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features. Wijetunga NA, Gessner KH, Kanchi K, Moore JA, Fleischmann Z, Jin DX, Frampton GM, Sturdivant M, Repka M, Sud S, Corcoran DL, Galsky MD, Milowsky MI, Wobker SE, Kim WY, Rose TL, Damrauer JS. Cancer Res Commun. 2024 Sep 1;4(9):2320-2334. doi: 10.1158/2767-9764.CRC-24-0352. PMID: 39113632
Influenza Virus and SARS-CoV-2 Vaccines. Sandor AM, Sturdivant MS, Ting JPY. J Immunol. 2021 Jun 1;206(11):2509-2520. doi: 10.4049/jimmunol.2001287. Epub 2021 May 21. PMID: 34021048
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy. DeVito NC, Sturdivant M, Thievanthiran B, Xiao C, Plebanek MP, Salama AKS, Beasley GM, Holtzhausen A, Novotny-Diermayr V, Strickler JH, Hanks BA. Cell Rep. 2021 May 4;35(5):109071. doi: 10.1016/j.celrep.2021.109071. PMID: 33951424
Role of dendritic cell metabolic reprogramming in tumor immune evasion. Plebanek MP, Sturdivant M, DeVito NC, Hanks BA. Int Immunol. 2020 Jun 26;32(7):485-491. doi: 10.1093/intimm/dxaa036. PMID: 32449776
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. Theivanthiran B, Evans KS, DeVito NC, Plebanek M, Sturdivant M, Wachsmuth LP, Salama AK, Kang Y, Hsu D, Balko JM, Johnson DB, Starr M, Nixon AB, Holtzhausen A, Hanks BA. J Clin Invest. 2020 May 1;130(5):2570-2586. doi: 10.1172/JCI133055. PMID: 32017708